Advertisement

Topics

Team Novo Nordisk Company Profile

10:21 EDT 26th September 2018 | BioPortfolio


News Articles [693 Associated News Articles listed on BioPortfolio]

Novo Nordisk Aktie: Novo Nordisk nimmt neue Märkte ins Visier!

Liebe Leser, Novo Nordisk ist den meisten Anlegern aufgrund seiner Diabetes-Medikamente bekannt. Bekanntlich ist es jedoch nie eine gute Idee, all sein Geld auf ein einziges Pferd zu setzen. Deshal...

Novo Nordisk-Aktie: Entscheidend ist die Nachrichtenlage

Kulmbach (www.aktiencheck.de) - Novo Nordisk-Aktienanalyse von "Der Aktionär": Marion Schlegel, Redakteurin beim Anlegermagazin "Der Aktionär", nimmt die Aktie von Novo Nordisk (ISIN: DK0060534915,....

Insulinhersteller Novo Nordisk kauft britisches Start-Up

Der dänische Insulinhersteller Novo Nordisk verstärkt sein Diabetes-Geschäft mit einem Zukauf. Wie Novo Nordisk am Freitag in Kopenhagen mitteilte, übernimmt der Konzern das britische Start-Up Ziy...

Kallyope and Novo Nordisk Team Up To Tackle Obesity

New York-based Kallyope and Danish company Novo Nordisk A/S signed a research collaboration and option deal to discover novel therapeutics to treat obesity and diabetes.

Jefferies senkt Ziel für Novo Nordisk auf 300 Kronen - 'Hold'

Das Analysehaus Jefferies hat das Kursziel für Novo Nordisk von 315 auf 300 dänische Kronen gesenkt und die Einstufung auf "Hold" belassen. Unter den europäischen Pharma-Aktien sei Novo Nordisk fü...

Novo Nordisk Eliminating 400 Jobs in R&D Restructuring

Novo Nordisk said today it will eliminate 400 R&D employees in its headquarters country of Denmark and China, in a restructuring the company said was designed to accelerate the expansion and diver...

Novo Nordisk to lay off 400 employees in Denmark and China

Novo Nordisk has announced plans to lay off around 400 staff in research and development (R&D) roles at its China...Read More... The post Novo Nordisk to lay off 400 employees in Denmark and China...

Epigen to license LPA1 receptor small molecule program to Novo Nordisk

Epigen Biosciences has entered into a collaboration agreement with Novo Nordisk, under which Novo Nordisk has licensed the LPA1 receptor antagonist EPGN696 for development in diabetic and chronic kidn...

Drugs and Medications [42 Associated Drugs and Medications listed on BioPortfolio]

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

Novolin [Novo Nordisk]

NOVOLIN N Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL

Up and up sensitive toothpaste enamel strengthening formula plus whitening [Team Technologies, Inc]

UP & Up Sensitive Toothpaste Enamel Strengthening formula plus whitening

Up and up anticavity toothpaste whitening [Team Technologies, Inc]

Up and Up anticavity toothpaste whitening

Novolin [Novo Nordisk]

Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin)

PubMed Articles [673 Associated PubMed Articles listed on BioPortfolio]

Do Long-time Team-mates Lead to Better Team Performance? A Social Network Analysis of Data from Major League Baseball.

To estimate the effects of team-mate shared experience on overall team performance as well as to determine whether concentration of time together among subgroups of players and/or focal players enhanc...

Diabetes News.

More than 2,000 attendees gathered in Vienna, Austria in mid-February for the 11annual Advanced Technologies and Treatments for Diabetes (ATTD) meeting. There, Dr David Klonoff presented results from ...

Bouncing Back from Setbacks: On the Mediating Role of Team Resilience in the Relationship Between Transformational Leadership and Team Effectiveness.

The purpose of this study was to clarify the role of team resilience on different facets of effectiveness (team viability and quality of the group experience). Moreover, given the importance of team r...

Effects of designated leadership and team-size on cardiopulmonary resuscitation: The Basel-Washington SIMulation (BaWaSim) trial.

During cardiopulmonary resuscitation (CPR), it remains unclear whether designating an individual person as team leader compared with emergent leadership results in better team performance. Also, the e...

Patient Drug Safety Reporting: Diabetes Patients' Perceptions of Drug Safety and How to Improve Reporting of Adverse Events and Product Complaints.

Global health care manufacturer Novo Nordisk commissioned research regarding awareness of drug safety department activities and potential to increase patient feedback. Objectives were to examine patie...

Clinical Trials [1281 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Effects of Different Interventions on Glycemic Control in Newly-Diagnosed Type 2 Diabetic Patients

The purpose of this study is to investigate and evaluate the effects of different interventions (1.continuous subcutaneous insulin infusion,2.multiple daily injections, 3.anti-hyperglycemi...

To Study Generic Estradiol 10 mcg Vaginal Tablets in the Treatment of Vulvar and Vaginal Atrophy in Post Menopausal Women.

This is a Randomized, Parallel-Group, Placebo- Controlled, Multicenter Study to Evaluate the Therapeutic Equivalence and Safety of Estradiol Vaginal Tablets 10 mcg and Vagifem® (Estradiol...

Evaluation of an Algorithm for Intensive s.c. Insulin Therapy in Emergency Room Patients With Hyperglycaemia

The aim of this study is to test the safety and efficacy of a new algorithm for intensive s.c. insulin injection in medical emergency patients with hyperglycaemia (plasma glucose concentra...

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

This trial is conducted in Europe. This trial aims to ensure that there is no substantial clinically relevant difference between the two Novo Nordisk needles NovoFine® 6 x 0.30 mm and Nov...

Comparison of a Blood Clotting Drug (Recombinant Factor XIII) Produced by Two Different Manufacturers in Healthy Male Subjects

This trial is conducted in Europe. The aim of this clinical trial is to compare the metabolism of a blood-clotting drug (recombinant Factor XIII) produced by two different manufacturers (N...

Companies [668 Associated Companies listed on BioPortfolio]

Novo Nordisk, Inc.

Novo Nordisk is a global healthcare company with more than 87 years of innovation and leadership in diabetes care. The company also has leading positions within hemophilia care, growth hormone therapy...

Novo A/S

Novo A/S is fully owned by the Novo Nordisk Foundation and is the holding company of the Novo Group. Novo A/S is a private limited liability company and the majority shareholder in the publicly listed...

Novo Nordisk A/S

Novo A/S, the holding company of the Novo Group, is fully owned by the Novo Nordisk Foundation and was established to manage the Foundation's funds and to invest actively in other companies. What make...

Team Novo Nordisk

Novo Nordisk

Novo Nordisk is a healthcare company and a world leader in diabetes care. The company has the broadest diabetes product portfolio in the industry, including the most advanced products within the area ...

More Information about "Team Novo Nordisk" on BioPortfolio

We have published hundreds of Team Novo Nordisk news stories on BioPortfolio along with dozens of Team Novo Nordisk Clinical Trials and PubMed Articles about Team Novo Nordisk for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Team Novo Nordisk Companies in our database. You can also find out about relevant Team Novo Nordisk Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record